Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders
Sign Up to like & getrecommendations! Published in 2019 at "Cellular and Molecular Life Sciences"
DOI: 10.1007/s00018-019-03178-2
Abstract: As life expectancy increases worldwide, age-related neurodegenerative diseases will increase in parallel. The lack of effective treatment strategies may soon lead to an unprecedented health, social and economic crisis. Any attempt to halt the progression of these diseases… read more here.
Keywords: alzheimer disease; tissue inhibitors; disease; inhibitors alzheimer ... See more keywords
THE ROLE OF MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF METALLOPROTEINASES IN DUCHENNE MUSCULAR DYSTROPHY CARDIOMYOPATHY
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(18)31419-0
Abstract: Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD). Better understanding of molecular pathways leading to DMD fibrosis may provide novel targets for drug therapy. Matrix metalloproteinases (MMPs) and tissue inhibitors of… read more here.
Keywords: muscular dystrophy; tissue inhibitors; inhibitors metalloproteinases; duchenne muscular ... See more keywords